Shanghai, China The usual cause for the fund is to invest in rounds with 8 partakers. Despite the Shanghai Chuangban Investment Management, startups are often financed by Tencent Holdings, Redpoint, CMC Capital Group. The meaningful sponsors for the fund in investment in the same round are Xiaomi, Tencent Holdings, Redpoint. In the next rounds fund is usually obtained by Alibaba Group.
Among the most popular fund investment industries, there are Apps, News. Among the most popular portfolio startups of the fund, we may highlight Qutoutiao. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
When the investment is from Shanghai Chuangban Investment Management the average startup value is more than 1 billion dollars. The higher amount of exits for fund were in 2018. Deals in the range of more than 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2018.
| Fund Name | Location |
| Ashland | Covington, Kentucky, United States |
| Attestor Capital LLP | England, London, United Kingdom |
| Certares | New York, New York, United States |
| China Yinhong | - |
| Core Learning Group | - |
| Cyber Communications | Japan, Tokyo |
| Emissions Reduction Alberta (ERA) | - |
| FSD Africa | Kenya, Nairobi, Nairobi Area |
| GateHub | England, London, United Kingdom |
| H. C. Wainwright & Co. | New York, New York, United States |
| Hatteras Funds | North Carolina, Raleigh, United States |
| Holman Growth Ventures | Pennsylvania, Philadelphia, United States |
| Jieshi Investment | - |
| Realiza Business Angels | Spain, Valencia, Valencian Community |
| Risk Management Solutions | California, Newark, United States |
| Ruizhi Zhuoneng | Beijing, Beijing, China |
| Speedshield | - |
| Xiamen Qingwa Juncheng Venture Capital | China, Fujian, Xiamen |
| ZG Ventures | District of Columbia, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Skynor Medical | 20 Jan 2021 | Shanghai, Shanghai, China | |||
Qutoutiao | $200M | 14 Mar 2018 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Skynor Medical | 20 Jan 2021 | Shanghai, Shanghai, China | |||
Qutoutiao | $200M | 14 Mar 2018 | Shanghai, China |
